(Sharecast News) - Dechra Pharmaceuticals announced the departure of one of its longstanding executives, Tony Griffin, on Monday.
The FTSE 100 company said Griffin, who had spent 12 years with the company, was immediately stepping down from his position as an executive director.
Griffin had also expressed his intention to retire as managing director of DVP Europe, effective 31 December.
As a result of his decision not to seek re-election at the upcoming 2023 annual general meeting, Dechra said the relevant resolution had been withdrawn.
"I would like to take this opportunity to thank Tony for the significant contribution that he has made to the group during his tenure," said chief executive officer Ian Page.
"Tony joined us following the acquisition of Eurovet in 2013.
"This was a transformative acquisition, providing critical mass, new markets, a wide range of complementary products and additional expertise to our management team."
At 0810 GMT, shares in Dechra Pharmaceuticals were up 0.05% at 3,824p.
Reporting by Josh White for Sharecast.com.
